Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Story of the ALS-FTD continuum retold: rather two distinct entities.

Lulé DE, Aho-Özhan HEA, Vázquez C, Weiland U, Weishaupt JH, Otto M, Anderl-Straub S, Semler E, Uttner I, Ludolph AC.

J Neurol Neurosurg Psychiatry. 2018 Sep 26. pii: jnnp-2018-318800. doi: 10.1136/jnnp-2018-318800. [Epub ahead of print]

PMID:
30257969
2.

Screening for Cognitive Function in Complete Immobility Using Brain-Machine Interfaces: A Proof of Principle Study.

Lulé D, Hörner K, Vazquez C, Aho-Özhan H, Keller J, Gorges M, Uttner I, Ludolph AC.

Front Neurosci. 2018 Aug 15;12:517. doi: 10.3389/fnins.2018.00517. eCollection 2018.

3.

Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Andersen PM, Kuzma-Kozakiewicz M, Keller J, Aho-Oezhan HEA, Ciecwierska K, Szejko N, Vázquez C, Böhm S, Badura-Lotter G, Meyer T, Petri S, Linse K, Hermann A, Semb O, Stenberg E, Nackberg S, Dorst J, Uttner I, Häggström AC, Ludolph AC, Lulé D.

J Neurol. 2018 Jul;265(7):1600-1606. doi: 10.1007/s00415-018-8861-4. Epub 2018 May 4.

PMID:
29728768
4.

Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis.

Rosenbohm A, Nagel G, Peter RS, Brehme T, Koenig W, Dupuis L, Rothenbacher D, Ludolph AC; ALS Registry Study Group.

JAMA Neurol. 2018 May 1;75(5):600-607. doi: 10.1001/jamaneurol.2017.5129.

PMID:
29482216
5.

Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis.

Lulé D, Böhm S, Müller HP, Aho-Özhan H, Keller J, Gorges M, Loose M, Weishaupt JH, Uttner I, Pinkhardt E, Kassubek J, Del Tredici K, Braak H, Abrahams S, Ludolph AC.

Cortex. 2018 Apr;101:163-171. doi: 10.1016/j.cortex.2018.01.004. Epub 2018 Jan 31.

PMID:
29477906
6.

Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.

Rosenbohm A, Liu M, Nagel G, Peter RS, Cui B, Li X, Kassubek J, Rothenbacher D, Lulé D, Cui L, Ludolph AC; ALS Registry Swabia Study Group.

J Neurol. 2018 Apr;265(4):774-782. doi: 10.1007/s00415-018-8735-9. Epub 2018 Feb 1.

PMID:
29392461
7.

Existential decision-making in a fatal progressive disease: how much do legal and medical frameworks matter?

Weber C, Fijalkowska B, Ciecwierska K, Lindblad A, Badura-Lotter G, Andersen PM, Kuźma-Kozakiewicz M, Ludolph AC, Lulé D, Pasierski T, Lynöe N.

BMC Palliat Care. 2017 Dec 28;16(1):80. doi: 10.1186/s12904-017-0252-6.

8.

Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis.

Henstridge CM, Sideris DI, Carroll E, Rotariu S, Salomonsson S, Tzioras M, McKenzie CA, Smith C, von Arnim CAF, Ludolph AC, Lulé D, Leighton D, Warner J, Cleary E, Newton J, Swingler R, Chandran S, Gillingwater TH, Abrahams S, Spires-Jones TL.

Acta Neuropathol. 2018 Feb;135(2):213-226. doi: 10.1007/s00401-017-1797-4. Epub 2017 Dec 22.

9.

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker.

Kassubek J, Müller HP, Del Tredici K, Lulé D, Gorges M, Braak H, Ludolph AC.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):374-381. doi: 10.1136/jnnp-2017-316365. Epub 2017 Nov 3.

10.

Functional reorganization during cognitive function tasks in patients with amyotrophic lateral sclerosis.

Keller J, Böhm S, Aho-Özhan HEA, Loose M, Gorges M, Kassubek J, Uttner I, Abrahams S, Ludolph AC, Lulé D.

Brain Imaging Behav. 2018 Jun;12(3):771-784. doi: 10.1007/s11682-017-9738-3.

PMID:
28600740
11.

Intrinsic functional connectivity alterations in progressive supranuclear palsy: Differential effects in frontal cortex, motor, and midbrain networks.

Rosskopf J, Gorges M, Müller HP, Lulé D, Uttner I, Ludolph AC, Pinkhardt E, Juengling FD, Kassubek J.

Mov Disord. 2017 Jul;32(7):1006-1015. doi: 10.1002/mds.27039. Epub 2017 May 22.

PMID:
28544256
12.

An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS.

Poletti B, Carelli L, Solca F, Lafronza A, Pedroli E, Faini A, Ticozzi N, Ciammola A, Meriggi P, Cipresso P, Lulé D, Ludolph AC, Riva G, Silani V.

J Neurol. 2017 Jun;264(6):1136-1145. doi: 10.1007/s00415-017-8506-z. Epub 2017 May 13.

PMID:
28503706
13.

A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh Cognitive and Behavioural ALS Screen.

Keller J, Krimly A, Bauer L, Schulenburg S, Böhm S, Aho-Özhan HEA, Uttner I, Gorges M, Kassubek J, Pinkhardt EH, Abrahams S, Ludolph AC, Lulé D.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Aug;18(5-6):443-450. doi: 10.1080/21678421.2017.1313869. Epub 2017 Apr 19.

PMID:
28420245
14.

Epidemiology of amyotrophic lateral sclerosis in Southern Germany.

Rosenbohm A, Peter RS, Erhardt S, Lulé D, Rothenbacher D, Ludolph AC, Nagel G; ALS Registry Study Group.

J Neurol. 2017 Apr;264(4):749-757. doi: 10.1007/s00415-017-8413-3. Epub 2017 Feb 20.

PMID:
28220290
15.

Experience matters: neurologists' perspectives on ALS patients' well-being.

Aho-Özhan HE, Böhm S, Keller J, Dorst J, Uttner I, Ludolph AC, Lulé D.

J Neurol. 2017 Apr;264(4):639-646. doi: 10.1007/s00415-016-8382-y. Epub 2017 Jan 24.

PMID:
28120043
16.

An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases.

Poletti B, Carelli L, Solca F, Lafronza A, Pedroli E, Faini A, Zago S, Ticozzi N, Ciammola A, Morelli C, Meriggi P, Cipresso P, Lulé D, Ludolph AC, Riva G, Silani V.

Neurol Sci. 2017 Apr;38(4):595-603. doi: 10.1007/s10072-016-2807-3. Epub 2017 Jan 11.

PMID:
28078566
17.

Attitudes of Patients and Relatives Toward Disability and Treatment in Malignant MCA Infarction.

Neugebauer H, Schnabl M, Lulé D, Heuschmann PU, Jüttler E; IGNITE Study Group (Initiative of German NeuroIntensive Trial Engagement).

Neurocrit Care. 2017 Apr;26(2):311-318. doi: 10.1007/s12028-016-0362-7.

PMID:
27966092
18.

Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis.

Schulthess I, Gorges M, Müller HP, Lulé D, Del Tredici K, Ludolph AC, Kassubek J.

Sci Rep. 2016 Dec 8;6:38391. doi: 10.1038/srep38391.

19.

Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.

Steinacker P, Huss A, Mayer B, Grehl T, Grosskreutz J, Borck G, Kuhle J, Lulé D, Meyer T, Oeckl P, Petri S, Weishaupt J, Ludolph AC, Otto M.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):112-119. doi: 10.1080/21678421.2016.1241279. Epub 2016 Nov 5.

PMID:
27819158
20.

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis.

Keller J, Gorges M, Aho-Özhan HE, Uttner I, Schneider E, Kassubek J, Pinkhardt EH, Ludolph AC, Lulé D.

J Vis Exp. 2016 Oct 13;(116). doi: 10.3791/54634.

Supplemental Content

Loading ...
Support Center